LIFECORE BIOMEDICAL, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Amount
LIFECORE BIOMEDICAL, INC. (LFCR) reported Effective Income Tax Rate Reconciliation, Tax Credit, Amount of $539.00 thousand for the 12-month period ending 2025-05-25, per its 10-KT filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCredits · last filed 2026-03-16
- LIFECORE BIOMEDICAL, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2025 was $539.00K, a 4.05% increase from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2024 was $518.00K, a 15.22% decline from fiscal 2023.
- LIFECORE BIOMEDICAL, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2023 was $611.00K, a 40.14% increase from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2022 was $436.00K, a 28.05% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month |
|---|---|
| 2025-05-25 | $539.00K 10-KT · filed 2026-03-16 |
| 2024-05-26 | $518.00K 10-KT · filed 2026-03-16 |
| 2023-05-28 | $611.00K 10-K · filed 2024-08-26 |
| 2022-05-29 | $436.00K 10-K · filed 2024-08-26 |
| 2021-05-30 | $606.00K 10-K · filed 2024-03-20 |
| 2020-05-31 | $613.00K 10-K/A · filed 2023-03-16 |
| 2019-05-26 | $771.00K 10-K · filed 2021-07-29 |
| 2018-05-27 | $777.00K 10-K · filed 2020-08-14 |
| 2017-05-28 | $834.00K 10-K · filed 2019-08-01 |
| 2016-05-29 | $156.00K 10-K · filed 2018-08-09 |
| 2015-05-31 | $375.00K 10-K/A · filed 2018-03-15 |
| 2014-05-25 | $378.00K 10-K · filed 2016-08-01 |
| 2013-05-26 | $801.00K 10-K · filed 2015-07-31 |
| 2012-05-27 | $368.00K 10-K · filed 2014-08-01 |
| 2011-05-29 | $637.00K 10-K · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |